Antibodies in falciparum malaria: what matters most, quantity or quality?
- PMID: 1343695
- DOI: 10.1590/s0074-02761992000700038
Antibodies in falciparum malaria: what matters most, quantity or quality?
Abstract
In view of the recent demonstration that antibodies that are protective against Plasmodium falciparum malaria may act in collaboration with blood monocytes, we have investigated the isotype content of sera from individuals with defined clinical states of resistance or susceptibility to malaria. Profound differences in the distribution of each Ig subclass and particularly in the ratio of cytophilic versus noncytophilic antibodies were found. In protected subjects, two cytophilic isotypes, IgG1 and IgG3 were found to predominate. In non-protected subjects, i.e. children and primary attack adults, three different situations were encountered: a) an imbalance in which IgG2, a non-cytophilic class, predominated (mostly seen in primary attacks); b) an imbalance in which mostly IgM antibodies predominated (a frequent event in children) or c) less frequently, an overall low level of antimalarial antibodies. Of 33 non immune subjects studied all, except one, had one of the above defects. The function of total Ig presenting such an isotype imbalance was studied in vitro in Antibody-Dependent-Cellular-Inhibition assays. Not only did IgG from protected subjects cooperate efficiently with blood monocytes, whilst IgG from non-protected groups did not, but moreover the latter inhibit the in vitro effect of the former: in competition assays whole IgG from primary attack cases with increased IgG2 content, competed with IgG from immune adults, thus suggesting that non-protected subjects had antibodies to epitopes critical for protection, but that these antibodies are non functional.
Similar articles
-
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity.Infect Immun. 1992 Apr;60(4):1473-81. doi: 10.1128/iai.60.4.1473-1481.1992. Infect Immun. 1992. PMID: 1548071 Free PMC article.
-
Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria.Malar J. 2008 Sep 24;7:186. doi: 10.1186/1475-2875-7-186. Malar J. 2008. PMID: 18816374 Free PMC article.
-
Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.Acta Trop. 2015 Feb;142:47-56. doi: 10.1016/j.actatropica.2014.10.011. Epub 2014 Oct 24. Acta Trop. 2015. PMID: 25446174 Free PMC article.
-
Mechanisms of immune protection in the asexual blood stage infection by Plasmodium falciparum: analysis by in vitro and ex-vivo assays.Mem Inst Oswaldo Cruz. 1992;87 Suppl 5:145-9. doi: 10.1590/s0074-02761992000900023. Mem Inst Oswaldo Cruz. 1992. PMID: 1342712 Review.
-
Mechanisms of defense against P. falciparum asexual blood stages in humans.Immunol Lett. 1994 Jul;41(2-3):115-20. doi: 10.1016/0165-2478(94)90118-x. Immunol Lett. 1994. PMID: 8002025 Review.
Cited by
-
Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1.Front Immunol. 2019 Oct 4;10:2295. doi: 10.3389/fimmu.2019.02295. eCollection 2019. Front Immunol. 2019. PMID: 31636633 Free PMC article.
-
Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination.Front Immunol. 2019 Mar 15;10:439. doi: 10.3389/fimmu.2019.00439. eCollection 2019. Front Immunol. 2019. PMID: 30930896 Free PMC article. Clinical Trial.
-
IgG Subclass Switch in Volunteers Repeatedly Immunized with the Full-Length Plasmodium falciparum Merozoite Surface Protein 1 (MSP1).Vaccines (Basel). 2024 Feb 17;12(2):208. doi: 10.3390/vaccines12020208. Vaccines (Basel). 2024. PMID: 38400191 Free PMC article.
-
Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas.Malar J. 2022 Jan 4;21(1):6. doi: 10.1186/s12936-021-04020-6. Malar J. 2022. PMID: 34983540 Free PMC article.
-
Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models.Infect Immun. 2010 Jan;78(1):477-85. doi: 10.1128/IAI.00941-08. Epub 2009 Jul 6. Infect Immun. 2010. PMID: 19581391 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources